Mark G. Lebwohl

Mark G. Lebwohl is an American dermatologist and author who is Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology and the Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai in New York City.

Lebwohl's books include the book on dermatologic therapy, ''Treatment of Skin Disease'' (), as well as ''Atlas of the Skin and Systemic Disease'' (). He has authored more than 500 publications, multiple book chapters and has been named as one of New York Magazine’s “Best Doctors” every year since the inception of the annual list. Dr. Brian S. Kim is director of a Center for Neuroinflammation and Sensation named in Mark Lebwohl's honor at Icahn School of Medicine at Mount Sinai. Provided by Wikipedia
Showing 1 - 7 results of 7 for search 'Mark G. Lebwohl', query time: 0.03s Refine Results
  1. 1
    Treatment of psoriasis with crisaborole

    Treatment of psoriasis with crisaborole by Erica B. Lee, Mark G. Lebwohl, Jashin J. Wu

    Published 2019-02-01
    Get full text
    Article
  2. 2
    Spesolimab use in treatment of pyoderma gangrenosum

    Spesolimab use in treatment of pyoderma gangrenosum by Sophie H. Guénin, MSc, Saakshi Khattri, MD, Mark G. Lebwohl, MD

    Published 2023-04-01
    Get full text
    Article
  3. 3
    Cutaneous reaction reported after third Moderna COVID-19 vaccine

    Cutaneous reaction reported after third Moderna COVID-19 vaccine by Sophie H. Guénin, MSc, Mindy Kresch, BS, Emily Elbogen, PA, Mark G. Lebwohl, MD

    Published 2021-12-01
    Get full text
    Article
  4. 4
    Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis

    Posttreatment maintenance of therapeutic effect with fixed-combination halobetasol propionate 0.01%/tazarotene 0.045% lotion for moderate-to-severe plaque psoriasis by Mark G. Lebwohl, Linda Stein Gold, James Q. Del Rosso, Lawrence Green, Abby Jacobson

    Published 2022-05-01
    Get full text
    Article
  5. 5
    COVID-19 Vaccine-Induced Lichenoid Eruptions—Clinical and Histopathologic Spectrum in a Case Series of Fifteen Patients with Review of the Literature

    COVID-19 Vaccine-Induced Lichenoid Eruptions—Clinical and Histopathologic Spectrum in a Case Series of Fifteen Patients with Review of the Literature by Yonatan K. Sapadin, Elazar Mermelstein, Robert G. Phelps, Christopher F. Basler, JoAnn M. Tufariello, Mark G. Lebwohl

    Published 2023-02-01
    Get full text
    Article
  6. 6
    Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity [version 2; referees: 3 approved]

    Moderate-to-severe atopic dermatitis patients show increases in serum C-reactive protein levels, correlating with skin disease activity [version 2; referees: 3 approved] by Anjali S. Vekaria, Patrick M. Brunner, Ahmad I. Aleisa, Lauren Bonomo, Mark G. Lebwohl, Ariel Israel, Emma Guttman-Yassky

    Published 2017-10-01
    Get full text
    Article
  7. 7
    Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure

    Safety of Ixekizumab Treatment for up to 5 Years in Adult Patients with Moderate-to-Severe Psoriasis: Results from Greater Than 17,000 Patient-Years of Exposure by April Armstrong, Carle Paul, Luis Puig, Wolf Henning Boehncke, Michael Freeman, Hideshi Torii, Kim Papp, Christopher E. M. Griffiths, Andrew Blauvelt, Kristian Reich, Melinda Gooderham, Tadashi Terui, Lisa Renda, Noah Agada, Wen Xu, Gaia Gallo, Mark G. Lebwohl

    Published 2019-11-01
    Get full text
    Article

Search Tools: